22 Grants
2022
Repurposing FDA-approved agonists of HCAR2 as novel therapeutics for Alzheimer's Disease
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1RF1AG076610-01), $1,691,548USD, 2022-05-01 -- 2025-04-30
2021
Academic Leadership Award at the Indiana University School of Medicine
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5K07AG062809-02), $161,882USD, 2020-01-01 -- 2024-12-31
 
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis
BISSEL, STEPHANIE J⋅Lamb, Bruce T and Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1RF1AG074566-01), $2,333,674USD, 2021-09-30 -- 2024-08-31
 
Training Grant on Alzheimer's Disease and ADRD at Indiana University
Lamb, Bruce T⋅Landreth, Gary E and Saykin, Andrew J
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1T32AG071444-01), $505,646USD, 2021-05-01 -- 2026-04-30
2020
Academic Leadership Award at the Indiana University School of Medicine
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1K07AG062809-01A1), $161,882USD, 2020-01-01 -- 2024-12-31
 
Microglial hexokinase 2 as a therapeutic target in Alzheimer's disease
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1RF1AG068400-01), $2,043,711USD, 2020-09-15 -- 2024-08-31
2017
Functional Significance of Amyloid Dynamics and Deposition in the AD Brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5R01AG043522-06), $282,649USD, 08/01/2013 -- 05/31/2018
2016
Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 7RF1AG050597-02), $1,649,492USD, 04/01/2016 -- 03/31/2021
 
Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1RF1AG050597-01A1), $1,981,250USD, 04/01/2016 -- 03/31/2021
 
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
Goldstein, Harris⋅HARVEY, BRANDON K⋅Karn, Jonathan and Landreth, Gary E
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 4R01DA036171-04), $708,347USD, 07/01/2013 -- 03/31/2018
 
Functional significance of amyloid dynamics and deposition in the AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 4R01AG043522-04), $324,925USD, 08/01/2013 -- 05/31/2018
 
Functional Significance of Amyloid Dynamics and Deposition in the AD Brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 7R01AG043522-05), $211,122USD, 08/01/2013 -- 05/31/2018
2015
Central and Peripheral Roles of TREM2 in Alzheimer's Disease
Lamb, Bruce T and Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1RF1AG051495-01), $3,566,258USD, 09/30/2015 -- 08/31/2020
 
Central and Peripheral Roles of TREM2 in Alzheimer's Disease
Lamb, Bruce T and Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 7RF1AG051495-02), $3,528,849USD, 09/30/2015 -- 06/30/2020
 
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
Goldstein, Harris⋅HARVEY, BRANDON K⋅Karn, Jonathan and Landreth, Gary E
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA036171-03), $706,181USD, 07/01/2013 -- 03/31/2018
 
Functional significance of amyloid dynamics and deposition in the AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5R01AG043522-03), $315,177USD, 08/01/2013 -- 05/31/2016
2014
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
Goldstein, Harris⋅HARVEY, BRANDON K⋅Karn, Jonathan⋅Landreth, Gary E and RANSOHOFF, RICHARD M
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA036171-02), $718,338USD, 07/01/2013 -- 03/31/2018
 
Functional significance of amyloid dynamics and deposition in the AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5R01AG043522-02), $324,925USD, 08/01/2013 -- 05/31/2018
2013
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
Goldstein, Harris⋅HARVEY, BRANDON K⋅Karn, Jonathan⋅Landreth, Gary E and RANSOHOFF, RICHARD M
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA036171-01), $734,339USD, 07/01/2013 -- 03/31/2018
 
Functional significance of amyloid dynamics and deposition in the AD brain
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R01AG043522-01A1), $324,925USD, 08/01/2013 -- 07/31/2018
2007
Liver X Receptors as Therapeutic Targets in Alzheimer?s Disease
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R21AG029926-01), $20,521USD, 07/15/2007 -- 08/31/2007
2004
UHC/CWRU ALZHEIMER'S DISEASE RESEARCH CENTER
Landreth, Gary E
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5P50AG008012-16), $2,249,912USD, 09/21/1988 -- 05/31/2007